FDA Inspection 1342162 — Istituto Di Ricerche Biomediche Antoine Marxer RBM S.P.A.
The FDA completed an inspection of Istituto Di Ricerche Biomediche Antoine Marxer RBM S.P.A. on Jul 12, 2024 in Colleretto Giacosa. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Colleretto Giacosa (Italy)
Additional Details
Mutual Recognition Agreement (MRA)